The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes in advanced cervical cancer (CC) and endometrial cancer (EC) patients (pts) treated in phase I trials of novel molecularly targeted agents (MTAs).
 
Angela George
No Relationships to Disclose
 
Vasiliki Michalarea
No Relationships to Disclose
 
Saeed Rafii
No Relationships to Disclose
 
Caroline O Michie
No Relationships to Disclose
 
Mabel Wong
No Relationships to Disclose
 
Rebecca Bowen
No Relationships to Disclose
 
Liz Y. Han
No Relationships to Disclose
 
Tom van Hagen
No Relationships to Disclose
 
Grigorios Rallis
No Relationships to Disclose
 
Udai Banerji
No Relationships to Disclose
 
Rebecca Sophie Kristeleit
Honoraria - Clovis Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Novartis
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
Johann Sebastian De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - Arno Therapeutics (Inst); AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Susana N. Banerjee
No Relationships to Disclose
 
L Rhoda Molife
No Relationships to Disclose
 
Martin Eric Gore
No Relationships to Disclose
 
Stanley B. Kaye
Honoraria - AstraZeneca
 
Timothy Anthony Yap
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Janssen-Cilag; MSD Oncology